Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ resapp health limited

Resapp Covid Safe Respiratory Consultation on your phone. Covid...

First 3054 Last

Share
Profile

Follow
Myeverywish

3,464 Posts.

956

20/12/21

23:36

Post #: 58424594
Share

Originally posted by MyBentley ↑

Telehealth on the rise should now be
Telehealth Covid Safe Medicine...

Resapp has the only regulatory approved software that turns a mobile phone into a medical device to diagnose respiratory illness during a telehealth GP consult.

When the penny drops...
Like Medgate expanding their telehealth platform globally.
Alodokter...to bring in 30 million active users during a respiratory pandemic...30 million having a chat or appointment

I would say that if a patient having a chat for free with a doctor and says to the doctor ...Dokter I have a bit of a cough...
The doctor will tap into a screen for symptoms and tick patient has cough.
I believe at this point Resapp dx test will be a recommended test to sell for $10.00. Maybe _$8.00. Resapp $5 Alodokter $3.00. Easiest _$9 million for a quarter for Alodokter ...

I believe it is possible for Resapp dx to get over 1 million uses a month during this Covid pandemic
At $5.00 a use..._15 million a quarter

All my opinion
I believe RAP is a unicorn
If if if revenue that matches my prediction ..

Imagine what the share price is

$wow.oo
MB

Expand

Resapp Covid Safe Respiratory Consultation on your phone.

Covid Safe ..Respiratory Medicine
Face to Face
On your phone
Resapp dx

MB

RAP Price at posting: 5.9¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

There are more pages in this discussion • 21 more messages in this thread...

First 3054 Last

Add RAP (ASX) to my watchlist

SPONSORED BY